FIELD: veterinary medicine.
SUBSTANCE: invention relates to a ready-to-use veterinary composition for injection containing sodium cefovecin, a biocompatible oil and a non-aqueous solvent. The biocompatible oil is a dicaprylate/dicaprate of propylene glycol in an amount from 58 to 68, wt. %, of the total mass of the composition, and the non-aqueous solvent is benzyl benzoate in an amount of 12 to 25, wt. %, of the total mass of the composition. The invention also relates to a method for treating bacterial infection in an animal in need by introducing an effective amount of cefovecin into a ready-to-use composition. The use of a veterinary composition for injection for the preparation of a drug for the treatment of bacterial infection in an animal is also claimed.
EFFECT: invention provides a composition of sodium cefovecin, which has a higher viscosity at low shear forces, thereby minimizing particle deposition and tracking of suspended cephalosporin, and having a lower viscosity at high shear force to maximize suspensibility and suitability for syringing.
14 cl, 5 dwg
Title |
Year |
Author |
Number |
HIGHLY CONCENTRATED COMPOSITIONS OF MONOCLONAL ANTIBODIES |
2013 |
- Armstrong Nikolas Dzh.
- Bauen Mayumi N.
- Maa Yuj-Fan
|
RU2711089C2 |
HIGHLY CONCENTRATED FORMULATIONS OF MONOCLONAL ANTIBODIES |
2013 |
- Armstrong, Nicholas J.
- Bowen, Mayumi N.
- Maa, Yuh-Fun
|
RU2827884C2 |
COMPOSITIONS OF LONG-TERM ACTION BASED ON KETOPROFEN |
2014 |
- Ivin Richard Endryu
- Khu Stiven Ks.
- Makhkovech Syuzan M.
- Menning Barton Kh.
- Sikrist Stiven Li
|
RU2646829C1 |
ANTIPARASITIC COMPOSITIONS TO BE USED BY POURING |
2018 |
- Sheehan, John, Gerard
- Freehauf, Keith
- Flochlay-Sigognault, Annie
|
RU2802299C2 |
INJECTABLE ISOXAZOLINE PHARMACEUTICAL COMPOSITIONS AND THEIR USE |
2018 |
- Freehauf, Keith, A
- Carrillo, Brian
|
RU2799591C2 |
PHARMACEUTICAL COMPOSITIONS AND METHOD OF TREATING INFLAMMATORY IN CATTLE AND OTHER ANIMALS |
2007 |
- Midous Chejni
- Frikhauf Kejt Alan
- Simmons Robert D.
- Vejngarten Allan Dzh.
|
RU2466715C2 |
LIQUID PHARMACEUTICAL COMPOSITION OF GABAPENTIN (OPTIONS) |
2022 |
- Zherlitsyn Stanislav Nikolaevich
- Khomishin Dmitrii Vladimirovich
|
RU2792628C1 |
PHARMACEUTICAL COMPOSITIONS OF 3-SUBSTITUTED 2-HYDROXYINDOLE-1-CARBOXAMIDES, METHOD OF INHIBITION OF COLLAGENASE ACTIVATION, METHOD OF INDUCING ANALGETIC RESPONSE, METHOD OF TREATMENT OF PATIENTS WITH INFLAMMATORY SICKNESSES |
1993 |
|
RU2119353C1 |
ABIRATERONE PRODRUGS |
2020 |
- Sharp Mettyu Dzh.
- Mur Uilyam R.
|
RU2822219C2 |
PHARMACEUTICAL COMPOSITION COMPRISING CYCLOSPORINE AS ACTIVE COMPONENT |
2000 |
- Singkh Amardzhit
- Dzhejn Radzhesh
|
RU2207870C2 |